USPTO serial 79325652
ANTIFEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 10, 2023
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ANTIFEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter S. Sloane
Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601-1523United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietetic foods and dietic foods for persons having complex metabolic disorders adapted for medical use; dietetic foods adapted for medical use; dietic foods adapted for medical use; food supplements for medical purposes; food supplements; nutritional supplements | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DMF PHARMA FOODAR S.R.L.
- Other trademarks owned by DMF PHARMA S.R.L.
- Other trademarks owned by DMF PHARMA S.R.L.
- Other trademarks owned by DMF PHARMA S.R.L.
- Other trademarks in Class 005
- Similar marks named ANTIFEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 25, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 25, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 25, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 25, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 24, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 17, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 25, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 25, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 10, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 3, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 10, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 10, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 25, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 25, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 5, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 16, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 15, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 15, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 15, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 15, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 22, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 26, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 26, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 23, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 22, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |